CPB (CPF)
(Delayed Data from NYSE)
$20.76 USD
+0.81 (4.06%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $20.75 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth B Momentum C VGM
Income Statements
Fiscal Year end for CPB Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 329 | 281 | 262 | 258 | 258 |
Cost Of Goods | 63 | 11 | 4 | 10 | 24 |
Gross Profit | 266 | 269 | 258 | 247 | 234 |
Selling & Adminstrative & Depr. & Amort Expenses | 180 | 165 | 148 | 194 | 148 |
Income After Depreciation & Amortization | 87 | 105 | 110 | 53 | 86 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 10 | 6 | 4 | 4 | 8 |
Pretax Income | 77 | 99 | 106 | 49 | 78 |
Income Taxes | 18 | 25 | 26 | 12 | 20 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 59 | 74 | 80 | 37 | 58 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 59 | 74 | 80 | 37 | 58 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 97 | 117 | 129 | 76 | 104 |
Depreciation & Amortization (Cash Flow) | 11 | 13 | 20 | 22 | 18 |
Income After Depreciation & Amortization | 87 | 105 | 110 | 53 | 86 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 27.08 | 27.57 | 28.26 | 28.18 | 28.68 |
Diluted EPS Before Non-Recurring Items | 2.17 | 2.68 | 2.83 | 1.32 | 2.03 |
Diluted Net EPS (GAAP) | 2.17 | 2.68 | 2.83 | 1.32 | 2.03 |
Fiscal Year end for CPB Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 89.29 | 82.46 | 79.76 | 77.82 |
Cost Of Goods | NA | 20.67 | 18.19 | 14.01 | 10.01 |
Gross Profit | NA | 68.62 | 64.27 | 65.75 | 67.80 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 47.18 | 44.49 | 44.22 | 43.96 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 21.44 | 19.78 | 21.53 | 23.84 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | 2.30 | 2.29 | 2.58 | 2.60 |
Pretax Income | NA | 19.14 | 17.49 | 18.95 | 21.25 |
Income Taxes | NA | 4.27 | 4.35 | 4.47 | 5.06 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 14.87 | 13.14 | 14.48 | 16.19 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 14.87 | 13.14 | 14.48 | 16.19 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 27.10 | 27.08 | 27.07 | 27.12 |
Diluted EPS Before Non-Recurring Items | NA | 0.55 | 0.49 | 0.53 | 0.60 |
Diluted Net EPS (GAAP) | NA | 0.55 | 0.49 | 0.53 | 0.60 |